ArticleFrontiers in oncology2026

Alectinib shows promise for the treatment of refractory ALK-positive large B-cell lymphoma: a case report.

Atheer Alsulami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.